Abstract
Conclusions
1. A total of 223 men recovered from myocardial infarction were allocated to treatment groups and serum cholesterol and phospholipids determined (I) before and (II) following 6 months of uninterrupted treatment with No estrogen, Premarin, Lynoral or Anvene. 2. The abnormality in interlipid relationships characteristic of men with clinical atherosclerosis was unaltered in the subjects receiving Premarin, but this abnormality was abolished by treatment with Lynoral. 3. There is no necessary correlation between the feminizing, lipid-altering and outcome-altering effects of estrogen therapy in men with myocardial infarction.
Get full access to this article
View all access options for this article.